drugset / Trial / NCT03686059
Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy
Timeline
- Start
- 2018-07-02
- Primary completion
- 2019-11-15
- Completion
- 2019-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omega-3 fatty acids | Unknown | 250 mg | — |